Skip to content
HowShorted

RHYTHM PHARMACEUTICALS, INC. short interest in 2024

In 2024, RHYTHM PHARMACEUTICALS, INC.'s disclosed short interest ran from 14.29% of shares outstanding on 12 Jan 2024 to 8.57% on 31 Dec 2024, a change of -5.72 percentage points. The year's high was 18.11% on 14 Jun 2024 and its low 8.57% on 31 Dec 2024, averaging 14.81% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 28.83 days on 30 Aug 2024. Full history: RHYTHM PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for RHYTHM PHARMACEUTICALS, INC. in 2024

2024 in figures

Start of year
14.29% (12 Jan 2024)
End of year
8.57% (31 Dec 2024)
Change
-5.72 pp
High
18.11% (14 Jun 2024)
Low
8.57% (31 Dec 2024)
Average
14.81%
Highest days to cover
28.83 (30 Aug 2024)
SEC filings marked
8

Every report in 2024

RHYTHM PHARMACEUTICALS, INC. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202414.29%9.90
31 Jan 202415.00%13.30
15 Feb 202414.83%12.66
29 Feb 202415.24%16.80results (8-K), 10-K filed
15 Mar 202415.56%15.62
28 Mar 202416.47%16.16
15 Apr 202417.26%19.68
30 Apr 202417.92%23.96
15 May 202416.93%15.0510-Q filed, results (8-K)
31 May 202417.92%24.38
14 Jun 202418.11%19.65
28 Jun 202415.15%13.20
15 Jul 202416.51%22.44
31 Jul 202416.70%21.88
15 Aug 202416.15%24.5110-Q filed, results (8-K)
30 Aug 202415.77%28.83
13 Sep 202415.28%22.36
30 Sep 202413.47%15.40
15 Oct 202413.84%28.16
31 Oct 202413.68%26.85
15 Nov 202410.92%7.21results (8-K), 10-Q filed
29 Nov 202410.36%12.19
13 Dec 20249.45%12.36
31 Dec 20248.57%9.02

See also: RHYTHM PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.